Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication-Reference-Cited by-同舟云学术

Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication

Published:2006-11 Issue:7119 Volume:444 Page:638-642
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Di Micco Raffaella,Fumagalli Marzia,Cicalese Angelo,Piccinin Sara,Gasparini Patrizia,Luise Chiara,Schurra Catherine,Garre’ Massimiliano,Giovanni Nuciforo Paolo,Bensimon Aaron,Maestro Roberta,Giuseppe Pelicci Pier,d’Adda di Fagagna Fabrizio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature05327.pdf

Reference30 articles.

1. Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864–870 (2005)

2. Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907–913 (2005)

3. Michaloglou, C. et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720–724 (2005)

4. Chen, Z. et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725–730 (2005)

5. Braig, M. et al. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436, 660–665 (2005)

Cited by 1516 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptotic metabolites ameliorate bone aging phenotypes via TCOF1/FLVCR1-mediated mitochondrial homeostasis;Journal of Nanobiotechnology;2024-09-06

2. PPM1D activity promotes cellular transformation by preventing senescence and cell death;Oncogene;2024-09-05

3. L3MBTL1, a polycomb protein, promotes Osimertinib acquired resistance through epigenetic regulation of DNA damage response in lung adenocarcinoma;Cell Death & Disease;2024-09-04

4. TICRR Overexpression Enhances Disease Aggressiveness and Immune Infiltration of Cutaneous Melanoma;Pharmacogenomics and Personalized Medicine;2024-09

5. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies;Cancer Treatment Reviews;2024-09